| Cat. No. |
Product Name |
CAS No. |
Information |
| PC-35278 |
UCB9608
|
1616413-96-7 |
UCB9608 (UCB-9608) is a potent, selective, orally bioavailable PI4KIIIβ inhibitor with IC50 of 11 nM. |
| PC-35202 |
GSK-A1
|
1416334-69-4 |
PI4KA inhibitor A1 (GSK-A1) is a highly specific and potent inhibitor of Phosphatidylinositol 4-kinase IIIα (PI4KIIIα). |
| PC-61695 |
BQR-695
|
1513879-21-4 |
BQR-695 (NVP-BQR695) is a highly potent, selective PI4KIIIβ inhibitor that has high potency against both the human (IC50 = 80 nM) and PvPI4K (IC50=3.5 nM) . |
| PC-61691 |
MMV390048
|
1314883-11-8 |
MMV390048 is a novel potent Plasmodium PI4K inhibitor with IC50 of 28 nM against intraerythrocytic life cycle stages of P. falciparum (NF54 drug-sensitive strain). |
| PC-61327 |
PI-273
|
925069-34-7 |
PI-273 (PI273) is a potent, specific, substrate-competitive small molecule inhibitor of PI4KIIα with IC50 of 0.47 uM. |
| PC-73080 |
AZ3
|
1608501-57-0 |
AZ3 (PI4KB inhibitor 3) is a seletive PI4KB inhibitor with pIC50 of 7.8, shows good lipid kinase selectivity (pIC50 5.1, 4.7 and 4.0 for PI4Kα, PI3Kα and PIP5Kγ respectively). |
| PC-73079 |
AZ7
|
1608501-54-7 |
AZ7 (PI4KA inhibitor 7) is a potent, selective PI4KA inhibitor with pIC50 of 8.2, >100-fold selectivity over PI4Kβ, PI3Kα and PIP5Kγ. |
